Pacific BioLabs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Pacific BioLabs is a well-established, privately-held contract research organization (CRO) that has served the life sciences industry for over 50 years. It operates as a service provider, offering a comprehensive suite of testing capabilities including in vivo, in vitro, and analytical services to support drug and medical device development from preclinical stages through manufacturing and clinical trials. The company differentiates itself through a strong focus on service quality, regulatory compliance, and its strategic location in the San Francisco Bay Area biotech hub. PBL is investing in digital transformation with a planned LIMS implementation and maintains key accreditations like ISO 17025.

DiagnosticsDrug Delivery

Technology Platform

Integrated service platform encompassing microbiology, in vivo toxicology, analytical chemistry, and cell-based in vitro bioassays. Supported by a cGMP/GLP compliant facility and a quality management system accredited to ISO 17025. Undergoing digital transformation with implementation of STARLIMS laboratory information management system (LIMS).

Opportunities

Growth is driven by strong outsourcing trends in biopharma, the dense concentration of biotech startups in the San Francisco Bay Area, and increasing complexity in regulatory testing for advanced therapies and combination products.

The recent ISO 17025 accreditation and national media feature provide platforms for expanding its client base and reputation.

Risk Factors

Faces intense competition from large global CROs and niche labs.

Revenue is susceptible to downturns in biotech funding and pharmaceutical R&D spending.

Operational reputation is entirely dependent on maintaining flawless regulatory compliance and data integrity, and the company faces execution risk in its digital transformation to a new LIMS system.

Competitive Landscape

Operates in the highly fragmented and competitive preclinical CRO market. Competitors range from large, full-service global organizations (e.g., Charles River Laboratories, LabCorp) to small, specialized testing laboratories. PBL differentiates through a focused service leadership model, deep regulatory expertise, and its strategic location serving the Bay Area biotech hub.

More companies in Diagnostics & Precision Medicine →More companies in United States →